arrow_back Back to App

Easier COVID-19 Testing and Support for Cellular Immune Response Research

This act aims to improve access to COVID-19 testing, including T-cell tests, by ensuring Medicare coverage. It also supports scientific research into the body's immune response, which could lead to a better understanding of the virus and the development of more effective treatments and vaccines. This means citizens will have broader access to diagnostics and a clearer understanding of COVID-19's impact on their health.
Key points
Medicare will cover T-cell diagnostic tests for COVID-19, making it easier to diagnose current or prior infections.
The U.S. government will develop a national strategy for COVID-19 cellular immune response research, including vaccine and natural immunity effects.
Research will focus on understanding T-cell immunity in various populations, including children, the elderly, immunocompromised individuals, and those with long-term COVID-19 symptoms.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_5745
Sponsor: Rep. Dunn, Neal P. [R-FL-2]
Process start date: 2021-10-27
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

COVID–19 Access to Testing and Support for Immune Response Research Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_5745.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-10-27.

What are the main provisions?

Key points include:

  • Medicare will cover T-cell diagnostic tests for COVID-19, making it easier to diagnose current or prior infections.
  • The U.S. government will develop a national strategy for COVID-19 cellular immune response research, including vaccine and natural immunity effects.
  • Research will focus on understanding T-cell immunity in various populations, including children, the elderly, immunocompromised individuals, and those with long-term COVID-19 symptoms.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Dunn, Neal P. [R-FL-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health